Response Biomedical Announces Strategic Alliances in Japan with Alere Medical and Long Time Partner Shionogi

December 8, 2015

December 08, 2015 – Response Biomedical Corp. VANCOUVER, British Columbia – December 8, 2015 – Response Biomedical Corp. (“Response” or “the Company”) (TSX: RBM, OTCQB: RPBIF), a commercial stage in-vitro diagnostics company with products for the laboratory and point of care markets, today reported a restructuring of the marketing of its BNP (B-type natriuretic peptide) … Continue reading Response Biomedical Announces Strategic Alliances in Japan with Alere Medical and Long Time Partner Shionogi

18th Annual LifeSciences BC Awards, presented by FARRIS – Call for Nominations

December 4, 2015

December 04, 2015 – LifeSciences BC CALL FOR NOMINATIONS LifeSciences BC’s 18th Annual LifeSciences BC Awards, presented by FARRIS on April 21, 2016, is an opportunity for the life sciences community to celebrate our work together. Recognizing the value creation continuum of the life sciences sector, we celebrate and honour those in our B.C. community … Continue reading 18th Annual LifeSciences BC Awards, presented by FARRIS – Call for Nominations

Conquer Mobile PeriopSim Selected for ‘100 Nurses’ Research Study into Surgical Simulation Education and Training for Nurses

December 04, 2015 – Conquer Mobile Conquer Mobile, Simulation Training Specialist, Announces that PeriopSim Has Been Selected as the Simulation Technology for the ‘100 Nurses’ Research Study into the Effectiveness of Simulation Training for Perioperative Nurses. The Study is Being Led by Dr. David Clarke, Head of Neurosurgery at Dalhousie University/Nova Scotia Health Authority and … Continue reading Conquer Mobile PeriopSim Selected for ‘100 Nurses’ Research Study into Surgical Simulation Education and Training for Nurses

Zymeworks announces it has entered into a collaboration and license agreement with GlaxoSmithKline (GSK)

December 3, 2015

December 03, 2015 – Zymeworks Inc. Vancouver, Canada (December 3, 2015) – Zymeworks Inc. today announced that it has entered into a collaboration and license agreement with GlaxoSmithKline (GSK) for the research, development, and commercialization of novel Fc-engineered monoclonal and bi-specific antibody therapeutics which have been optimized for specific therapeutic effects. Under the terms of … Continue reading Zymeworks announces it has entered into a collaboration and license agreement with GlaxoSmithKline (GSK)

Natalie Dakers, CEO, Accel-Rx – Canada’s Health Sciences Accelerator is the National Winner of the 2015 Startup Canada Award for Entrepreneur of the Year Award

December 1, 2015

December 01, 2015 – Accel-Rx Health Sciences Accelerator December 1, 2015, Toronto, ON –  Natalie Dakers CEO of Accel-Rx has been named by Startup Canada as the national winner of the Startup Canada Award for Entrepreneur of the Year Award and will accept the award at a red carpet ceremony at the CN Tower in … Continue reading Natalie Dakers, CEO, Accel-Rx – Canada’s Health Sciences Accelerator is the National Winner of the 2015 Startup Canada Award for Entrepreneur of the Year Award

4D LABS joins Canada’s FACT Network

November 25, 2015

November 25, 2015 – 4D LABS KINGSTON, ON/BURNABY, BC — 4D LABS is pleased to announce that CMC Microsystems, on behalf of the Micro-Nano Technologies Laboratory Working Group, has welcomed 4D LABS at Simon Fraser University to the FACT network of labs, devoted to fabrication, assembly, characterization and test of micro-nano innovations. 4D LABS becomes … Continue reading 4D LABS joins Canada’s FACT Network

PRECISION NANOSYSTEMS WINS BC EXPORT AWARD FOR EMERGING EXPORTER

November 25, 2015 – PRECISION NANOSYSTEMS iNC. November 25th, 2015 – Vancouver, BC, Canada, Precision NanoSystems Inc. (PNI) was awarded the BC Export Award for Emerging Exporter. Nominees are deemed to be the “best of the best” of their respective sector and demonstrate significant contributions to the BC economy through economic growth in their community, … Continue reading PRECISION NANOSYSTEMS WINS BC EXPORT AWARD FOR EMERGING EXPORTER

Qu Biologics Completes Enrollment of Randomized Clinical Trial in Crohn’s Disease

November 24, 2015

November 24, 2015 – Qu Biologics Inc. Vancouver, British Columbia –  November 24, 2015 –  Qu Biologics Inc., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to restore normal immune function in the targeted organ, announced that it has completed enrollment of its QBECO-01 Crohn’s disease clinical trial, with top-line data expected in … Continue reading Qu Biologics Completes Enrollment of Randomized Clinical Trial in Crohn’s Disease

DelMar Pharmaceuticals Updates VAL-083 Clinical Trial in Refractory Glioblastoma Multiforme at Society for Neuro-Oncology Annual Meeting

November 23, 2015

November 23, 2015 – DelMar Pharmaceuticals Inc. Interim Phase II data supports clinically meaningful survival benefit in post bevacizumab refractory GBM Quarterly business update conference call with webcast today at 4:30 p.m. ET / 1:30 p.m. PT to incorporate data review VANCOUVER, British Columbia and MENLO PARK, Calif., Nov. 23, 2015 /PRNewswire/ — DelMar Pharmaceuticals, … Continue reading DelMar Pharmaceuticals Updates VAL-083 Clinical Trial in Refractory Glioblastoma Multiforme at Society for Neuro-Oncology Annual Meeting

Aeri Health Announces Partnership with The Lung Association’s Breathing as One Campaign, Launches New Mobile COPD App

November 18, 2015

November 18, 2015 – Aeri Health Toronto, Ont. and Vancouver B.C. – November 18, 2015 – The Lung Association, through its Breathing as One Research Campaign, and Aeri Health, a Vancouver-based integrated health management company, today announced the launch of a new partnership based around a new mobile app that will enable Canadians with Chronic … Continue reading Aeri Health Announces Partnership with The Lung Association’s Breathing as One Campaign, Launches New Mobile COPD App